1. Home
  2. TOUR vs SKYE Comparison

TOUR vs SKYE Comparison

Compare TOUR & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOUR
  • SKYE
  • Stock Information
  • Founded
  • TOUR 2006
  • SKYE 2012
  • Country
  • TOUR China
  • SKYE United States
  • Employees
  • TOUR N/A
  • SKYE N/A
  • Industry
  • TOUR Transportation Services
  • SKYE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOUR Consumer Discretionary
  • SKYE Health Care
  • Exchange
  • TOUR Nasdaq
  • SKYE Nasdaq
  • Market Cap
  • TOUR 98.6M
  • SKYE 101.3M
  • IPO Year
  • TOUR 2014
  • SKYE N/A
  • Fundamental
  • Price
  • TOUR $0.85
  • SKYE $3.48
  • Analyst Decision
  • TOUR
  • SKYE Buy
  • Analyst Count
  • TOUR 0
  • SKYE 7
  • Target Price
  • TOUR N/A
  • SKYE $15.50
  • AVG Volume (30 Days)
  • TOUR 227.2K
  • SKYE 284.4K
  • Earning Date
  • TOUR 08-15-2025
  • SKYE 08-07-2025
  • Dividend Yield
  • TOUR 4.26%
  • SKYE N/A
  • EPS Growth
  • TOUR N/A
  • SKYE N/A
  • EPS
  • TOUR 0.03
  • SKYE N/A
  • Revenue
  • TOUR $75,532,120.00
  • SKYE N/A
  • Revenue This Year
  • TOUR $16.99
  • SKYE N/A
  • Revenue Next Year
  • TOUR $13.23
  • SKYE N/A
  • P/E Ratio
  • TOUR $25.62
  • SKYE N/A
  • Revenue Growth
  • TOUR 7.57
  • SKYE N/A
  • 52 Week Low
  • TOUR $0.75
  • SKYE $1.14
  • 52 Week High
  • TOUR $1.76
  • SKYE $7.11
  • Technical
  • Relative Strength Index (RSI)
  • TOUR 56.42
  • SKYE 49.27
  • Support Level
  • TOUR $0.82
  • SKYE $3.22
  • Resistance Level
  • TOUR $0.85
  • SKYE $3.60
  • Average True Range (ATR)
  • TOUR 0.05
  • SKYE 0.26
  • MACD
  • TOUR 0.01
  • SKYE 0.01
  • Stochastic Oscillator
  • TOUR 82.00
  • SKYE 65.82

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: